bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.08.23.457193

Assessment of antimicrobial activity of ethanolic and aqueous extracts of Aesculus hippocastanum L. (horse chestnut) bark against bacteria isolated from urine of patients diagnosed positive to urinary tract infections.

Abstract

The search for new antimicrobials is essential to address the worldwide issue of antibiotic resistance which affects all areas requiring the use of antibiotics including the management of diseases such as urinary tract infections (UTIs). AimTo assess the antimicrobial activity of ethanolic and aqueous extract of Aesculus hippocastanum L. (horse chestnut) bark. Material and MethodBioactive compounds were extracted from A. hippocastanum bark using water and ethanol as solvent. The extracts were tested against 10 clinical strains isolated from urine of patients diagnosed positive to urinary tract infections and including five Gram-positive bacteria (Kocuria rhizophila 1542, Enterococcus avium 1669, Staphylococcus simulans 5882, Conybacterium spp 1638, Enterococcus faecalis 5960) and five Gram-negative (Proteus mirabilis 1543, Morganella morganii 543, Citrobacter freundi 426, Acynetobacter baumannii 5841 and Achromobacter xylosoxidans 4892). Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 25922 were used as standard Gram+ and Gram-respectively. The susceptibility of the test strains to antibiotic was assessed using the Kirby Bauer disc diffusion method while the antibacterial activity of the extracts was evaluated using the well diffusion method. We finally determined the Minimum inhibitory concentration (MIC) and the minimum bactericidal concentrations (MBC) by the microdilution method. ResultsA. hippocastanum bark possessed a dry matter content of 65.73%. The volume yield of the ethanolic and aqueous extract (AE) was 77,77% and 74,07% (v/v), respectively, whereas their mass yields were 13,4% and 24,3% (w/w), respectively. All the bacteria were susceptible to amoxiclav, imipenem and ceftriaxone, both standard bacteria (E. coli ATCC 25922 and S. aureus ATCC 6538) were sensitive to all antibiotics while the clinical strains were resistant to at least one antibiotic. K. rizophilia 1542 and Conybacterium spp 1638 were the most resistant bacteria both with multidrug resistance index of 0.45. Except AE on P. Mirabilis 1543 and E. faecalis 5960 (0 mm), both AE and EE were active against all the microorganisms tested with inhibition diameters (mm) which ranged from 5.5-10.0 for AE and 8.0-14.5 for EE. The MICs of EEs varied from 1-4 mg/ml while those of EAs varied from 4-16 mg/ml. Almost all the MBCs of AEs were indeterminate (>64 mg/ml) while those of EE were successfully determined. The ethanolic extracts (EE) were overall more active than the aqueous ones. ConclusionThe A. hippocastanum bark extracts had overall weak antibacterial activity (MIC [≥]0.625 mg/ml) and bacteriostatic potential (MBC/MIC [≥]16) on both Gram-positive and Gram-negative bacteria. Therefore, studies with other solvents (such as methanol and chloroform), other extraction techniques, and synergy tests with conventional antibiotics are needed to conclude on a potential better antimicrobial activity of this plant material.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yuriy, K., Joseph Arsene, M. M., Aliya, M. V., Viktorovna, P. I., Elena, V. G.. 2021-08-25. Assessment of antimicrobial activity of ethanolic and aqueous extracts of Aesculus hippocastanum L. (horse chestnut) bark against bacteria isolated from urine of patients diagnosed positive to urinary tract infections.. https://doi.org/10.1101/2021.08.23.457193

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology